Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
allogeneic cell therapy
Biotech
Allogene links solid tumor CAR-T to responses, deaths in phase 1
Allogene linked the off-the-shelf cell therapy to a 33% response rate but also three deaths in heavily pretreated kidney cancer patients.
Nick Paul Taylor
Nov 8, 2024 4:47am
New biotech aims to boost thymus Tolerance
Oct 15, 2024 10:15am
Capricor shares more data for DMD therapy after initiating BLA
Oct 11, 2024 11:50am
Astellas telegraphs new cell therapy site in Japan, 24 US layoffs
Oct 9, 2024 5:45pm
Acepodia, Pfizer click together for chemistry-based cell therapy
Sep 3, 2024 5:00pm
Viral protein suppresses graft vs. host disease in mice
Jul 19, 2024 5:30am
